KERENDIA® (finerenone)
Search documents
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
Businesswire· 2025-11-06 16:44
Core Points - Bayer AG has appointed Dr. Judith Hartmann as the new Chief Financial Officer (CFO), effective June 1, 2026, succeeding Wolfgang Nickl who will retire at the end of May 2026 [1][2] - Dr. Hartmann has extensive international experience, having held leadership roles at ENGIE and Bertelsmann, and is currently an Operating Partner at Sandbrook Capital [1][2] - The Chairman of the Supervisory Board, Professor Dr. Norbert Winkeljohann, expressed confidence in Dr. Hartmann's ability to contribute significantly to Bayer's future [2] Company Background - Bayer AG is a global enterprise focused on life sciences, particularly in health care and nutrition, with a mission of "Health for all, Hunger for none" [5] - The company aims to drive sustainable development and create value through innovation and growth, employing around 93,000 people and generating sales of 46.6 billion euros in fiscal 2024 [6]